• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec7
Prime Medicine Releases Clinical Data for Gene Therapy PM359
13:21
Nov8
Prime Medicine released FY2025 9 Months Earnings on November 7, 2025 (EST) with actual revenue of USD 3.794M and EPS of USD -1.1186
04:00
Prime Medicine released FY2025 Q3 earnings on November 7 (EST), actual revenue USD 1.225 M (forecast USD 2.801 M), actual EPS USD -0.3151 (forecast USD -0.2562)
04:00
Nov7
The Company to Present PM577's Preclinical Data at AASLD and Nominate PM647 as AATD Development Candidate
13:04
Aug10
Chardan Capital cuts Prime Medicine target price to $10.00
21:00
Aug8
Prime Medicine released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 1.115 M (forecast USD 3 M), actual EPS USD -0.4099 (forecast USD -0.3816)
03:00

Schedules & Filings

Schedules
Filings
Nov7
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.225 M, Net Income -50.58 M, EPS -0.3151

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.115 M, Net Income -52.59 M, EPS -0.407

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.454 M, Net Income -51.89 M, EPS -0.3964

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
VMAR
0.9760
+156.77%
+0.596
AMCI
14.650
+101.51%
+7.380
RILY
5.720
+53.76%
+2.000
CPAC
10.640
+52.22%
+3.650
EDHL
0.5472
+43.40%
+0.166
ADGM
1.180
+41.95%
+0.349
EEX
4.950
+39.83%
+1.410
CHOW
1.080
+38.09%
+0.298
MSOX
9.500
+37.48%
+2.590
BDRX
6.500
+35.98%
+1.720
View More